The 3rd Biogen Idec-sponsored meeting of MS and ALS researchers in Quebec and Montpellier France will be held at the Neuro on October 15 and 16, 2015. This meeting is co-organized by the Neuro...
Low levels of vitamin D significantly increase the risk of developing multiple sclerosis (MS), according to a study led by Dr. Brent Richards of the Lady Davis Institute at the Jewish General...
A new study led by researchers at the Montreal Neurological Institute and Hospital of McGill University and the MUHC, gets closer to identifying the mechanisms responsible for multiple sclerosis...
In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary...
RSS